BTC$77,213▼ 0.39%
ETH$2,116▼ 0.78%
SOL$85.65▲ 0.78%
HYPE$57.73▲ 15.29%
XRP$1.36▼ 0.53%
BNB$649.20▲ 0.73%
DOGE$0.1045▲ 0.50%
AVAX$9.31▲ 0.70%
LINK$9.58▼ 0.12%
TAO$278.80▲ 5.59%
ZEC$661.59▲ 13.74%
NEAR$1.76▲ 7.73%
BTC$77,213▼ 0.39%
ETH$2,116▼ 0.78%
SOL$85.65▲ 0.78%
HYPE$57.73▲ 15.29%
XRP$1.36▼ 0.53%
BNB$649.20▲ 0.73%
DOGE$0.1045▲ 0.50%
AVAX$9.31▲ 0.70%
LINK$9.58▼ 0.12%
TAO$278.80▲ 5.59%
ZEC$661.59▲ 13.74%
NEAR$1.76▲ 7.73%
RSS
Follow-Up ·
Token no longer active · checked 05 September 2026

This token no longer has a tradeable liquidity pool. That is down 100% from the $6,824 reported when this article was published. The figures below describe conditions at the time of writing and do not reflect the token's current state.

Intismeran (VACCINE) Has $6,824 of Liquidity Left Since We Covered It

What Happened

Intismeran (VACCINE) currently has a liquidity of $6,824. This marks a significant decline from the $69,391.56 liquidity reported when this site last covered it.

VACCINE price chart, 104 candles to Aug 19, 2026
TA · Downtrend — price below EMA-20 and EMA-50 · RSI 30 (oversold) · near the bottom of its range · liquidity $6.8k · pool 9h old
Snapshot captured
What the model flagged, and what happened scored 51.6/100 Elevated at coverage

Liquidity measured $6,824 against $69,392 at coverage — down 90.2%. Measured against Intismeran (VACCINE) Gains 22.8% on a 4.0 Hours-old Pool With No Track Record to Assess.

  • Pair maturity4.0 hoursBorne out
    Flagged because a pair this new had no trading history to stand on.
  • Liquidity depth$69,392Borne out
    Flagged because a pool this thin would not absorb exits.
Never visible to the model
  • Team identity, track record, and off-chain commitments
  • Whether locked liquidity unlocks soon — only the current lock state is read
  • Coordinated wallets that spread supply to look decentralised
  • Social-media manipulation and paid promotion
  • Anything in a contract's logic beyond the standard checks performed

This is one token measured against its own coverage. It is not evidence the score is predictive — a token failing does not prove the coverage was right, and one surviving does not prove it was wrong. These follow-ups are only written when a pool has collapsed, so flags will tend to read as borne out here; that is a property of which tokens get a follow-up, not a measure of how often the model is right. The corpus-wide test, covering every token including those that survived, is on the track record. Not financial advice.

Token
This article has no stored risk assessment. The token page carries a live assessment and every article published about VACCINE.
Risk assessment and coverage for VACCINE →

What We Said At The Time

In our original article published on August 19, 2026, we classified Intismeran (VACCINE) under the "Elevated" risk band with a risk score of 51.6. The coverage noted the token's recent gain of 22.8% on a pool that was only 4.0 hours old, highlighting the absence of a track record for assessment.

What This Shows

The current liquidity figures indicate a severe degradation in the token's market health since our last report. The drastic drop from $69,391.56 to $6,824 reflects the critical findings regarding the liquidity conditions flagged originally.

Current State

  • Current liquidity: $6,824
  • Liquidity at publication: $69,391.56
  • Last checked: August 19, 2026, 21:04:06 UTC

Risk Note

This article does not constitute financial advice.